The supplier of extrusion technology Fibre Extrusion Technology Ltd. (FET), Leeds/UK, since its launch in 2015, has taken 50 orders for the FET-100 series, with a value of more than US$20 million.
This pilot and laboratory scale melt spinning system can be specified to be multi-functional, allowing for easy and fast conversion between material formats. It configures to all combinations of multifilament, monofilament and melt spinning of nonwoven structures, as required.
The FET-100 has been particularly successful in the biomedical and composite sectors since its upgrade to meet the requirements in these demanding fields. This equipment is highly suitable for the development and small volume production of exotic and difficult-to-process biomedical materials, such as resorbable polymers used in medical devices. These include the engineering polymers such as PPSU, PEI, PEEK and PC. FET systems are also suitable for processing sustainable polymer types (S-polyamides, PLA, PHA, S-PET etc.).
For composite applications, this equipment facilitates the development and small volume production of pre-cursor synthetic textile materials used in the manufacture of high performance composites. These include so-called “engineering polymers” such as PPSU, PEI, PEEK and PC polycarbonates. FET systems are also suitable for processing sustainable polymer types (S-Polyamides, PLA, PHA, S-Pet etc), ideal for the production of bio-degradable composite materials.
The FET-100 Series is complemented by the company’s in-house process development laboratory which allows client trials, proof of concept testing, collaborative research, sampling and prototyping.